Belgian Building Stock News

Why the latest FINTEPLA data matters for UCB stock UCB (ENXTBR:UCB) is in focus after new EpilepsiaOpen data on FINTEPLA in Lennox Gastaut syndrome reported sustained seizure reductions, early improvements in global functioning, and an overall acceptable long term tolerability profile. For investors tracking UCB stock, this product update raises fresh questions about how FINTEPLA fits within the group’s broader neurology portfolio and what the findings might mean for long term revenue...

The European market has faced a mix of resilient economic data and geopolitical uncertainties, with the STOXX Europe 600 Index experiencing a slight decline recently. In this context, penny stocks—often smaller, newer companies—remain an intriguing investment area despite being considered somewhat outdated as a term. These stocks can offer growth potential at lower price points when supported by strong financials, making them attractive options for investors looking to uncover hidden gems in...

European student flows are being rewired in real time as UK universities face a 58% drop in EU undergraduate applications and campuses in Italy, the Netherlands, Belgium and France attract more English‑taught degrees. That shift is quietly reshaping demand for higher education services and student housing. This article walks through 3 stocks that are closely tied to this trend and explains how each could either benefit or fall behind. The stocks below are just a starting sample from this...

KBC Group NV reported higher net income and earnings per share for the second quarter and first half of 2026, raised its full‑year guidance for net interest income and total income, and confirmed an interim dividend of €1 per share to be paid in November 2026. Together, the upgraded guidance and maintained interim dividend suggest management confidence in the bank‑insurer’s current operating performance and income‑generating capacity. Next, we’ll examine how KBC’s higher 2026 earnings...

Recent commentary points to rising analyst optimism around Anheuser-Busch InBev (ENXTBR:ABI), driven by upward revisions to earnings estimates and expectations for above average EPS growth. This has brought fresh attention to the stock. See our latest analysis for Anheuser-Busch InBev. The latest analyst optimism comes against a backdrop where Anheuser-Busch InBev’s share price has risen strongly year to date, with a 28.01% year-to-date share price return and a 35.27% total shareholder return...

Shurgard Self Storage stock closed at €24.65 today, with the recent 7 day slide and 30 day decline suggesting investors are reacting nervously to the latest earnings. The headline is not revenue, which sits at €115.054m for the quarter. The real story is pressure on profitability as adjusted earnings and net operating income growth trail the expansion of the store pipeline and rentable space. In the very near term that squeeze is what the market is trading. Over a multi year horizon the...

Cenergy Holdings (ENXTBR:CENER) has drawn attention after strong half year 2026 earnings, a higher full year guidance range for adjusted EBITDA, and a record order backlog supported by a large Greek grid frame agreement. See our latest analysis for Cenergy Holdings. Cenergy Holdings’ share price has moved to €22.32, with a 42.17% year to date share price return and a 1 year total shareholder return of 97.87%, while the 3 month share price return has declined 15.45%. This suggests strong...

Shareholders of Lotus Bakeries NV ( EBR:LOTB ) will be pleased this week, given that the stock price is up 11% to...

Syensqo (ENXTBR:SYENS) is back in focus after reporting second quarter and first half 2026 results, with quarterly sales at €1,611 million and quarterly net income at €24 million. See our latest analysis for Syensqo. Since the earnings release on 30 July 2026, Syensqo’s share price has pushed higher, with a 30 day share price return of 23.79% and a 90 day share price return of 36.05%, suggesting momentum has been building. The 1 year total shareholder return of 10.35% points to more modest...

The EU’s new anti dumping tariffs on terephthalic acid have suddenly shifted the ground under Europe’s chemicals and specialty materials stocks. Supply routes into a €1.4b market are being rewired, which can change pricing power and margins for certain producers. This article looks at three European stocks directly exposed to this news and explains how each could be affected, so you can decide whether they deserve a closer look now. The stocks covered below are just a starting sample, and the...

What Azelis Group’s latest earnings tell you Azelis Group (ENXTBR:AZE) has just reported half year 2026 results, giving investors fresh numbers to assess the stock. Sales and revenue were slightly above the prior year, with net income and earnings per share also higher. See our latest analysis for Azelis Group. The latest half year earnings have arrived alongside a sharp pick up in momentum for Azelis Group, with a 1 month share price return of 16.21% and a year to date share price return of...

Bpost/SA went into this earnings release with the stock already under pressure, down around 19% over the past three months and closing at €1.36 on 7 August. The headline is simple: the earnings report sharpened the focus on a profit squeeze that investors were already worrying about. Management cut full year adjusted earnings before interest and tax guidance to about €140m after a costly April strike and a slower revenue ramp at Paxon. Quarterly revenue of €1,046.4m and another small net loss...

Lotus Bakeries stock went into this earnings print priced for perfection, trading on a trailing P/E of 56.9x against far lower food sector averages. The market had already rewarded the story, with double digit revenue and earnings growth over the past year, so any hint of strain was always going to hit sentiment hard. The real hinge of this release is valuation pressure. The shares sit well above a discounted cash flow estimate of €8,005.35, which puts every line of the H1 2026 report under a...

Investors in Nyxoah SA ( EBR:NYXH ) had a good week, as its shares rose 3.9% to close at €1.27 following the release of...

Earnings setback puts Proximus stock in focus Proximus (ENXTBR:PROX) is back on investors' radar after first half 2026 results showed lower sales, revenue, and net income compared with a year earlier, sharpening attention on the company's earnings power. See our latest analysis for Proximus. Since the July earnings announcement, Proximus has seen its share price slip 1.3% on the day and 2.3% over the past week. However, the 30 day share price return is up 6.9% while the 1 year total...

Jensen-Group’s stock has slipped over the past week and month, even as the latest earnings landed with a very different message. The market is trading the recent softness, yet the fresh report shows a laundry equipment specialist that is still producing solid profit and cash generation. The tension comes from one place: margins are thinner than a year ago, with net profit margin over the last twelve months sitting below the prior period. That squeeze is colliding with a P/E of 12.3x that...

Anheuser-Busch InBev SA/NV's ( EBR:ABI ) robust earnings report didn't manage to move the market for its stock. Our...

Why NV Bekaert’s latest earnings matter for shareholders NV Bekaert (ENXTBR:BEKB) has just reported half year 2026 results that show lower sales but higher net income and earnings per share compared with the same period last year. That mix deserves closer attention. For the half year to 30 June 2026, the company reported sales of €1,863.27m compared with €1,953.08m a year earlier. Over the same period, net income was €94.31m compared with €81.72m. Basic earnings per share from continuing...

Warehouses De Pauw trades like a quiet income REIT at €22.32, and the latest numbers put the balance sheet and valuation debate back in the spotlight. The stock sits at a discount to one widely used fair value model while carrying a higher P/E than many direct peers. At the same time, earnings over the past year include a sizeable one off gain and profit margins have compressed, which matters for a sector built on steady cash flows. For investors, the key issue this quarter is the tension...

Ontex Group stock closed at €2.315 after a choppy few months, with the share price down roughly 20% over ninety days. The market has been wrestling with a simple question: is this just a cheap, troubled hygiene products producer or a deeply discounted turnaround story? The latest half year results put that tension in sharp focus. Adjusted EBITDA for H1 2026 landed at €78m, with margins still under pressure and a large €144m impairment charge tied to a sweeping transformation review. The rest...

Fagron stock closed at €23.20 on Friday, rounding off a month where the share price drifted about 3% lower despite a fresh set of half year numbers. On a short view the market looks lukewarm. On a longer view the headline is different. Earnings per share over the trailing twelve months sit at €1.25 and the P/E multiple of 18.5x still sits below healthcare peers. The key tension this season is not the income statement. It is the balance sheet. High debt remains the central issue that long term...

UCB walked into this earnings print with a stock that had lost ground, down about 9% over the past week and 14% over the past month, even as trailing earnings and valuation looked supportive. The headline today is earnings power. Basic earnings per share for the first half of 2026 came in at €5.83 and trailing twelve month earnings reached €11.52 per share, underpinned by €2.19b of net income from continuing operations. The market had already priced in worry. The earnings show a business that...

As the pan-European STOXX Europe 600 Index edges higher amidst robust corporate earnings and geopolitical tensions, investors are closely monitoring the implications of rising oil prices and potential interest rate changes by the European Central Bank. In this dynamic environment, dividend stocks can offer a stable income stream, making them an attractive option for those looking to navigate market fluctuations while benefiting from regular payouts.

argenx (ENXTBR:ARGX) has put up another busy quarter, with Q2 2026 revenue at roughly US$1.5 billion and basic EPS of US$7.57, while trailing twelve month revenue sits at about US$5.3 billion and EPS at US$27.72, supported by net income of US$1.7 billion over that period. Over recent quarters the company has seen revenue move from US$967.63 million in Q2 2025 to US$1.54 billion in Q2 2026, alongside basic EPS stepping from US$4.02 to US$7.57. This sets the stage for investors to focus on how...